Hematocrit (HCT) Interference and Correction

Hematocrit (HCT) Interference and Correction

Hematocrit (HCT) is the share of your blood's volume made up of red blood cells. On a meter that doesn't compensate for it, a low hematocrit tends to push a fingerstick reading too high, and a high hematocrit pushes it too low[1][2]. Every meter is labeled for a hematocrit range, the span over which its maker showed accurate results. When we lined up the FDA summaries, those ranges varied more than we expected: 10 to 65% for the Accu-Chek Guide, 20 to 60% for the OneTouch Verio[3][4].

Which way the error runs

The direction has held up across studies done years apart. In a 2000 laboratory study, researchers ran six handheld meters at hematocrits of 19.1%, 38.5% and 58.3%. Most of them read high at the low hematocrit and low at the high one, whatever reference method they were calibrated to[2]. For several meters, the size of the error also depended on the glucose level[2].

The authors of a 2013 study summed up the earlier research the same way. Hematocrit below normal (under 30 to 35%) leads strip meters to overestimate laboratory glucose, and hematocrit above normal (over 45%) leads them to underestimate it[1].

Why red blood cells get in the way

Here's what surprised us: the mechanism still isn't settled. The 2013 authors wrote that it "is not entirely understood" and listed the leading explanations[1]:

• Red cells change how thick (viscous) the blood is.
• They can keep plasma from reaching the strip's reaction surface.
• They change how quickly glucose diffuses through the sample.
• At a high hematocrit, packed red cells displace plasma, leaving too little of it in the sample for an accurate test.

Each of these fits the direction of the error described above. None of them has been shown to be the whole story.

Who falls outside the usual range

Instructions for many meters have limited use to hematocrit of roughly 30 to 50%, which matches a healthy reference population[1]. Real patients spread wider. A large dataset cited in the 2013 study found hematocrits from 20 to 60% in more than 15,000 community patients and 10 to 70% in more than 45,000 hospital patients[1].

Hematocrit also moves within one person. The same paper lists smoking, prolonged exercise, high altitude, age, blood disorders, heavy menstrual bleeding, pregnancy and kidney disease as causes. It adds that a healthy adult's value can differ by up to about 15% (relative) between its yearly high and low points[1].

How meters correct for it

The 2013 study described two broad approaches[1]. One adds a separate electrode that measures hematocrit, then applies a correction factor to the glucose result. Nova Biomedical's StatStrip point-of-care meter works this way, and the company's Nova Max Plus and Nova Max Link home meters use the same strip technology[1]. The other relies on what the authors call dynamic electrochemistry: the sensor signal is corrected with mathematical equations before the result appears on screen[1]. We go deeper into that math in Hematocrit Interference Correction Algorithms.

Manufacturers rarely publish the details. The FDA summary for the Accu-Chek Guide says only that "the sample and the environmental conditions are evaluated using AC and DC signals"[3].

Labeled hematocrit ranges for current meters

As of October 2026, these are the claimed ranges we found in FDA 510(k) decision summaries:

• Accu-Chek Guide: 10 to 65%. The summary describes 30 replicates on 30 meters at ten hematocrit levels across that span, for each strip lot and glucose level tested[3].
• OneTouch Verio Flex and Verio Reflect: 20 to 60% each[5][6]. FDA cleared the same range for the original OneTouch Verio meter in 2011, when its predicate, the OneTouch Ultra 2, was listed at 30 to 55%[4].
• Contour Next strips: the claim depends on the meter. The Contour Next One system was cleared for 15 to 65%[7], while the Contour Next GEN system was cleared for 20 to 55%[8].
• True Metrix: 20 to 70%[9]. Separately, an FDA safety communication issued April 28, 2026 recommends that all True Metrix users, including store-brand versions, move to another way of testing when possible because of an E-5 error-code problem unrelated to hematocrit. The FDA also says users shouldn't stop testing until they have that alternative[10].

The Contour pair taught us the most. Both meters use Contour Next strips, yet their claimed ranges differ[7][8], so a hematocrit range describes a meter-and-strip system rather than the strip alone.

What a head-to-head lab test showed

The 2013 study adjusted donor blood to five hematocrit levels between 25 and 65% and tested 19 meter types available in the US at the time[1]. Only six kept their mean hematocrit effect under the authors' 10% limit, led by the OneTouch Verio at 3%; the Accu-Chek Active came in at 7%[1]. The Accu-Chek Aviva, Accu-Chek Aviva Nano, OneTouch Ultra 2 and Contour did not meet the criteria, and the FreeStyle Freedom Lite just missed at 11%[1].

Two cautions apply. Nova Biomedical funded the study, and two of the six passing meters were Nova's[1]. The authors also point out that they used manipulated venous blood in a lab, while the meters are designed for fingertip capillary blood[1]. We read it as a snapshot of meters sold around 2012, not a ranking of what's on shelves in 2026.

Checking your own meter

Your meter's labeling states the hematocrit range it was cleared for[1][3]. If you know your hematocrit runs low or high, for example because of a blood disorder, kidney disease or pregnancy[1], it's worth comparing that number with the labeled range. Whether a different meter would serve you better is a decision to make with your care team.